Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
DPPE-PEG-CDI
1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] (sodium salt)-carboyl diimidazole
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-286 | 100mg | 550.00 | + Add to cart |
|
| R-C-286 | 200mg | 980.00 | + Add to cart |
|
|
||||
Product description
Immunoliposome administration is a potential therapy.Although immunoliposomes have specific binding effect on target cells in vitro,their targeting efficiency in vivo is relatively low.Suspension peg immunoliposomes have high targeting in vivo.
| Appearance | N/A |
|---|---|
| PEG Molecular Weight | 1000,2000,3400,5000,10000 Dalton |
| substitution by NMR | >95% |
| PDI by GPC | <1.5 |
| Solubility | Organic solvents |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds--DPPE-PEG-CDI Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
